ArticleBritish journal of clinical pharmacology2009

A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.

Matthijs L Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.